Fabla Mobile App for Diabetes
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a mobile app designed to help older adults manage diabetes. The app, called Fabla Mobile App, allows users to keep an audio diary to track their condition and assess improvements in health management. Participants should have type 1 or 2 diabetes along with another health issue, such as obesity or heart problems, and be comfortable using a smartphone app. The trial aims to determine if the app is user-friendly and improves diabetes management. As an unphased trial, this study provides a unique opportunity for participants to contribute to innovative research that could enhance diabetes management for many.
Do I have to stop taking my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications. It seems focused on using a mobile app for diabetes management, so it's likely you can continue your medications, but please confirm with the trial organizers.
What prior data suggests that the Fabla Mobile App is safe for older adults with diabetes?
In a previous study, researchers found that diabetes mobile apps can help improve blood sugar levels and are easy to use. This suggests they are generally safe for people with diabetes. However, the U.S. Food and Drug Administration (FDA) has warned about risks associated with certain diabetes apps. These warnings advise users to exercise caution, as specific phone settings might cause them to miss important alerts. Despite these concerns, many people use these apps safely to manage their diabetes. Users should always follow the instructions and stay informed about any safety updates.12345
Why are researchers excited about this trial?
The Fabla Mobile App is unique because it offers a novel approach for managing diabetes through a mobile application, specifically designed for older adults. Unlike traditional treatments that may involve medication or lifestyle changes, Fabla provides an interactive audio diary to help users track their condition and manage their diabetes in real time. Researchers are excited about this app because it not only caters to the tech-savvy older population but also integrates personalized feedback, which could improve adherence and outcomes. This app aims to empower users by making diabetes management more accessible and engaging, potentially leading to better health outcomes.
What evidence suggests that the Fabla Mobile App is effective for diabetes self-management?
Studies have shown that mobile apps can help people manage diabetes more effectively. For example, one study found that using a diabetes management app improved health outcomes and self-care habits in people with type 2 diabetes. Research also shows that regular use of these apps links to better control of blood sugar levels in everyday life. Reviews suggest that many diabetes apps can help lower HbA1c (a measure of average blood sugar levels over time), although more high-quality research is needed. Overall, these findings suggest that using a mobile app like Fabla, which participants in this trial will use, could support better diabetes management.46789
Who Is on the Research Team?
Wenhui Zhang, PhD
Principal Investigator
Emory University
Are You a Good Fit for This Trial?
This trial is for older adults diagnosed with type 1 or type 2 diabetes who also have at least one other health condition, like obesity or heart problems. Participants must be able to use a smartphone and understand English.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Feasibility Intervention
Participants use the Fabla-diabetesMM audio diary mobile application and complete structured surveys and audio diary entries
Follow-up
Participants are monitored for self-management outcomes and quality of life improvements
What Are the Treatments Tested in This Trial?
Interventions
- Fabla Mobile App
Trial Overview
The study is testing the feasibility of using an audio diary mobile app (Fabla-diabetesMM) to help people manage their diabetes and other health conditions. About 30 participants will try out the app.
How Is the Trial Designed?
1
Treatment groups
Experimental Treatment
Participants are older adults (≥65 years) with type 1 or type 2 diabetes and at least one comorbidity. All participants receive the adapted Fabla-diabetesMM audio diary mobile application and complete structured surveys and audio diary entries over 7 days and up to 1-3 months.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Emory University
Lead Sponsor
Citations
Mobile apps for diabetes self-management: An updated ...
Although higher-quality research is needed, current reviews suggest that many diabetes apps are effective in lowering HbA1c.
A Mobile App for Diabetes Management: Impact on Self ... - PMC
The mobile app helped patients with type 2 diabetes in a community hospital improve therapeutic outcome and self-management behavior.
Effect of smartphone apps on glycemic control in young ...
The current pooled data analysis did not reveal a significant reduction in HbA1c in young patients with T1D undergoing treatment with smartphone apps and usual ...
The Effects of Continuous Usage of a Diabetes ...
Our analysis shows that continuous usage of the diabetes management app is associated with better glycemic control in real-world clinical practice.
Evaluation of Mobile Applications for Patients with ...
Our findings indicated that diabetes mobile apps allowed for convenient user experience and improved blood sugar levels in patients with diabetes.
Evaluation of Mobile Applications for Patients with Diabetes ...
Our findings indicated that diabetes mobile apps allowed for convenient user experience and improved blood sugar levels in patients with diabetes.
7.
theeducatedpatient.com
theeducatedpatient.com/view/expert-weighs-in-fda-alert-highlights-hidden-risks-in-diabetes-appsFDA Alert Highlights Hidden Risks in Diabetes Apps
Last week, the U.S. Food and Drug Administration (FDA) issued a safety alert for patients using diabetes devices, including continuous ...
8.
facebook.com
facebook.com/Local4/posts/us-officials-are-warning-about-a-potentially-life-threatening-issue-with-smartph/1045402914298944/US officials are warning about a potentially life
U.S. officials are warning about a potentially life-threatening issue with smartphone apps that help manage diabetes.
smartdm2 - App Store - Apple
This app is designed to synthesize treatment pathway guidelines developed by the American Diabetes Association, the American Association of Clinical ...
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.